Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Reckitt Benckiser Group plc
  6. News
  7. Summary
    RKT   GB00B24CGK77

RECKITT BENCKISER GROUP PLC

(RKT)
  Report
Delayed London Stock Exchange  -  11:35 2022-10-06 am EDT
5940.00 GBX   -0.07%
05:18aRECKITT : Deutsche Bank reiterates its Buy rating
MD
10/03RECKITT : Buy rating from Barclays
MD
10/03RECKITT : Credit Suisse gives a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Reckitt Benckiser : FDA Approves Importing of PurAmino Formula to US

08/11/2022 | 02:11am EDT
11 Aug 20222min read 12Views
RECKITT'S MEAD JOHNSON RECEIVES FDA APPROVAL TO IMPORT 6 MILLION SERVINGS OF SPECIALTY INFANT FORMULA TO U.S.

Shipment of PurAmino formula from Reckitt's nutrition facility in Mexico will feed some of America's most vulnerable babies

11 August, 2022 (Slough, UK) - We have received approval from the United States Food and Drug Administration (FDA) to import 150 metric tons (approx. 331,000 pounds) of infant formula base powder from Reckitt's nutrition facility in Delicias, Mexico. Once it is blended and packaged, in the United States, it will yield the equivalent of 6 million 8-oz servings of PurAmino, Mead Johnson's amino acid-based formula. This initial shipment of PurAmino will be produced in August, and is expected to be distributed immediately following the completion of Reckitt's stringent quality and safety checks in the U.S.

PurAmino specialty formula feeds infants and toddlers who cannot digest other types of formula because of a cow's milk protein allergy, multiple food allergies, or a number of gastrointestinal conditions. This PurAmino formula will be distributed primarily through hospitals and other healthcare settings to ensure access to this medically critical product for the babies who need it.

Reckitt's state-of-the-art facility in Delicias, Mexico, which has been manufacturing infant formula since 1970, is our Latin American hub, already exporting products to 15 countries. Reckitt will deliver the PurAmino by ground transport to its facility in Zeeland, Michigan where it will be packaged and distributed via Mead Johnson's existing distribution network. Pat Sly, President of Reckitt's nutrition business, commented:

quote icon

"We appreciate the continued support from the government, our supply chain partners and employees globally, who have worked together to help end this shortage as quickly as possible, with the highest standards of safety and quality. Every step we can take to increase supply and get more formula to parents is vital, and the FDA's latest import approval will help us do just that."

Pat SlyPresident of Global Nutrition at Reckitt

To date, our ongoing efforts to increase access to infant formula include:

  • Currently feeding approximately 50% of all infants in the United States
  • Securing FDA approval to import base powder from our facility in Singapore
  • Scaling up and funding air freight for August and September base powder deliveries to the United States from Singapore
  • Operating our plants 24/7
  • Streamlining our product portfolio to maximize production capacity
  • Working with the U.S. government to resolve supply chain constraints
  • Partnering with retailers to expedite orders and prioritize formula at their distribution centers to fill shelves more quickly.

Disclaimer

Reckitt Benckiser Group plc published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 06:10:10 UTC.


© Publicnow 2022
All news about RECKITT BENCKISER GROUP PLC
05:18aRECKITT : Deutsche Bank reiterates its Buy rating
MD
10/03RECKITT : Buy rating from Barclays
MD
10/03RECKITT : Credit Suisse gives a Buy rating
MD
09/30RECKITT : Credit Suisse keeps its Buy rating
MD
09/29RECKITT : Receives a Buy rating from JP Morgan
MD
09/26Unilever CEO set to leave after GSK debacle, arrival of activist investor
RE
09/22Reckitt Benckiser : Time to Rethink How We Get More People Safe Water
PU
09/21Reckitt Benckiser : Answering the call for global action at UNGA
PU
09/21Fed day is upon us...
MS
09/21Reckitt Benckiser : Fighting Corruption & Pursuing Sustainable Growth
PU
More news
Analyst Recommendations on RECKITT BENCKISER GROUP PLC
More recommendations
Financials
Sales 2022 14 432 M 16 147 M 16 147 M
Net income 2022 2 468 M 2 761 M 2 761 M
Net Debt 2022 7 395 M 8 274 M 8 274 M
P/E ratio 2022 17,4x
Yield 2022 3,01%
Capitalization 42 511 M 47 563 M 47 563 M
EV / Sales 2022 3,46x
EV / Sales 2023 3,18x
Nbr of Employees 40 000
Free-Float 97,0%
Chart RECKITT BENCKISER GROUP PLC
Duration : Period :
Reckitt Benckiser Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECKITT BENCKISER GROUP PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 5 940,00 GBX
Average target price 7 309,20 GBX
Spread / Average Target 23,1%
EPS Revisions
Managers and Directors
Jeff Carr Chief Financial Officer & Executive Director
Christopher A. Sinclair Chairman
Nicandro Durante Senior Independent Non-Executive Director
Pamela J. Kirby Independent Non-Executive Director
Andrew Robert John Bonfield Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RECKITT BENCKISER GROUP PLC-6.34%47 851
CHURCH & DWIGHT CO., INC.-29.93%17 613
THE CLOROX COMPANY-25.40%16 219
PT UNILEVER INDONESIA TBK19.22%12 120
LION CORPORATION5.53%3 184
WD-40 COMPANY-27.39%2 540